NuVasive Inc. said Aug. 9 that it has formed a strategic partnership with Germany-based Siemens Healthineers.
MEDICINE: Bringing Services to the Consumer Is Trend in Health Care
Forget far-off appointments and long drives to the doctor’s office.
Competing congressional priorities are clouding the path forward for an effort to kill a 2.3 percent excise tax on medical device makers, San Diego’s NuVasive and ResMed among them.
Company is developing treatments for a broad range of diseases, including a variety of cancers and Alzheimer’s.
AMN Healthcare Services Inc., the San Diego-based health care staffing company, reported net income of $35.5 million on revenue of $558.1 million in the second quarter of 2018.
Special Report: Fastest-Growing Private Companies
It was his own battle with obesity that lead Drew Canole, founder of Organifi, down a path of educating others about making healthy choices and living healthy lives.
Neurocrine’s Ingrezza — the first treatment for the nervous system disorder tardive dyskinesia — continues to rake in revenue.
San Diego-based ResMed listed fourth quarter revenue as $623.6 million, a 12 percent year-over-year increase.
San Diego-based Dexcom’s stock hit $118.57 a share the morning of Aug. 2, up sharply from closing Aug. 1 at $95.44.
San Diego medical device company NuVasive reported $281.6 million in second quarter earnings, an 8.5 percent year-over-year jump.
San Diego-based Omniome, maker of a DNA sequencing platform, today announced a $60 million series B round.
Illumina in the second quarter reported revenue of $830 million, a 25 percent year-over-year increase.
Sublimity Therapeutics, an Irish pharmaceutical in the realm of gastrointestinal and immunological diseases, has set up a Solana Beach office with six employees.
PHARMA: A $230M Funding Round, Strong Leaders Are Big Pluses
By going big, Gossamer Bio looks to break the mold.
Molecular diagnostic company Mesa Biotech recently notched a $20 million series B round.